{"_buckets": {"deposit": "9a46650b-ba18-4adb-9d1c-ff5f098a827d"}, "_deposit": {"id": "14114", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "14114"}, "status": "published"}, "_oai": {"id": "oai:nagoya.repo.nii.ac.jp:00014114"}, "item_9_biblio_info_6": {"attribute_name": "\u66f8\u8a8c\u60c5\u5831", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2012-02", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "1-2", "bibliographicPageEnd": "30", "bibliographicPageStart": "19", "bibliographicVolumeNumber": "74", "bibliographic_titles": [{"bibliographic_title": "Nagoya Journal of Medical Science"}]}]}, "item_9_description_4": {"attribute_name": "\u6284\u9332", "attribute_value_mlt": [{"subitem_description": "Obesity is closely associated with an increased risk for metabolic and cardiovascular diseases. Adipose tissue produces a number of secretory bioactive substances, also known as adipocytokines or adipokines, which directly affect adjacent or distant organs. Most adipocytokines are pro-inflammatory, thereby promoting the obesity-linked disorders. In contrast, there are a small number of adipocytokines that exhibit antiinflammatory properties. It is now recognized that dysregulated production or secretion of adipocytokines caused by adipocyte dysfunction leads to the development of obesity-linked complications. In this review, we focus on the functional role of several adipocytokines in metabolic and cardiovascular diseases.", "subitem_description_type": "Abstract"}]}, "item_9_identifier_60": {"attribute_name": "URI", "attribute_value_mlt": [{"subitem_identifier_type": "URI", "subitem_identifier_uri": "http://www.med.nagoya-u.ac.jp/medlib/nagoya_j_med_sci/7412/7412.html"}, {"subitem_identifier_type": "HDL", "subitem_identifier_uri": "http://hdl.handle.net/2237/16019"}]}, "item_9_identifier_registration": {"attribute_name": "ID\u767b\u9332", "attribute_value_mlt": [{"subitem_identifier_reg_text": "10.18999/nagjms.74.1-2.19", "subitem_identifier_reg_type": "JaLC"}]}, "item_9_publisher_32": {"attribute_name": "\u51fa\u7248\u8005", "attribute_value_mlt": [{"subitem_publisher": "Nagoya University School of Medicine"}]}, "item_9_select_15": {"attribute_name": "\u8457\u8005\u7248\u30d5\u30e9\u30b0", "attribute_value_mlt": [{"subitem_select_item": "publisher"}]}, "item_9_source_id_7": {"attribute_name": "ISSN\uff08print\uff09", "attribute_value_mlt": [{"subitem_source_identifier": "0027-7622", "subitem_source_identifier_type": "ISSN"}]}, "item_creator": {"attribute_name": "\u8457\u8005", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "OUCHI, NORIYUKI"}], "nameIdentifiers": [{"nameIdentifier": "43870", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "OHASHI, KOJI"}], "nameIdentifiers": [{"nameIdentifier": "43871", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "SHIBATA, REI"}], "nameIdentifiers": [{"nameIdentifier": "43872", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "MUROHARA, TOYOAKI"}], "nameIdentifiers": [{"nameIdentifier": "43873", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "\u30d5\u30a1\u30a4\u30eb\u60c5\u5831", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2018-02-20"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "02_Ouchi.pdf", "filesize": [{"value": "339.1 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 339100.0, "url": {"label": "02_Ouchi.pdf", "url": "https://nagoya.repo.nii.ac.jp/record/14114/files/02_Ouchi.pdf"}, "version_id": "5db5fe9e-f57b-4e0d-8f72-c74a3e5c4e66"}]}, "item_keyword": {"attribute_name": "\u30ad\u30fc\u30ef\u30fc\u30c9", "attribute_value_mlt": [{"subitem_subject": "adipocytokine", "subitem_subject_scheme": "Other"}, {"subitem_subject": "adiponectin", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Sfrp5", "subitem_subject_scheme": "Other"}, {"subitem_subject": "adipolin", "subitem_subject_scheme": "Other"}, {"subitem_subject": "inflammation", "subitem_subject_scheme": "Other"}, {"subitem_subject": "cardiovascular disease", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "\u8a00\u8a9e", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "\u8cc7\u6e90\u30bf\u30a4\u30d7", "attribute_value_mlt": [{"resourcetype": "departmental bulletin paper", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "ADIPOCYTOKINES AND OBESITY-LINKED DISORDERS", "item_titles": {"attribute_name": "\u30bf\u30a4\u30c8\u30eb", "attribute_value_mlt": [{"subitem_title": "ADIPOCYTOKINES AND OBESITY-LINKED DISORDERS"}]}, "item_type_id": "9", "owner": "1", "path": ["499/508/509/1375"], "permalink_uri": "https://doi.org/10.18999/nagjms.74.1-2.19", "pubdate": {"attribute_name": "\u516c\u958b\u65e5", "attribute_value": "2012-02-28"}, "publish_date": "2012-02-28", "publish_status": "0", "recid": "14114", "relation": {}, "relation_version_is_last": true, "title": ["ADIPOCYTOKINES AND OBESITY-LINKED DISORDERS"], "weko_shared_id": 3}